yourstate.us
N.J. Stat. § 26:2K-71

Definitions relative to mobile intensive care paramedics

New Jersey · New Jersey Statutes Title 26 — Health and Vital Statistics · Status: effective

Get this as JSONEmbed this
Cite this
Citation
N.J. Stat. § 26:2K-71, Definitions relative to mobile intensive care paramedics, New Jersey, version 1 as recorded 2026-09-28, yourstate.us, https://yourstate.us/provision/1454532
Permanent ID
ys:prov:1454532@1
SHA-256
1e0827f2017adeb0a6e3a5f2c1035638905662aaf041e6140343b249022c8271

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

1. a. As used in this section: "Mobile intensive care paramedic" and "mobile intensive care unit" shall have the same meaning as provided in section 1 of P.L.1984, c.146 (C.26:2K-7). "Opioid antidote" shall have the same meaning as provided in section 1 of P.L.2017, c.116 (C.26:2K-66). b. Subject to the requirements of federal law, a mobile intensive care paramedic in this State who has responded to an emergency as a member of a dispatched mobile intensive care unit may administer buprenorphine, under the medical direction of a licensed, supervising physician, to an individual following the emergency administration of an opioid antidote to that individual provided that the mobile intensive care paramedic administering the buprenorphine: (1) is providing emergency medical services through a program that is registered with the United States Attorney General pursuant to subsection (j) of 21 U.S.C. s.823; (2) administers the buprenorphine consistent with all applicable requirements of federal law; and (3) has completed supervised comprehensive training and competency assessments within a mobile intensive care unit regarding which specific medical conditions necessitate the administration of buprenorphine, buprenorphine dosage requirements, and required medical documentation following the administration of buprenorphine.